Subscribe
shutterstock_473806648_amy_kerkemeyer
Amy Kerkemeyer / Shutterstock.com
18 November 2021AmericasAlex Baldwin

Judge approves Pfizer’s $345m EpiPen settlement

EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
EpiPen patent revoked in Europe
2 May 2018   The European Patent Office has revoked a patent covering Mylan’s EpiPen injector after finding that patent amendments contravened the European Patent Convention (EPC).
Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Europe
EpiPen patent revoked in Europe
2 May 2018   The European Patent Office has revoked a patent covering Mylan’s EpiPen injector after finding that patent amendments contravened the European Patent Convention (EPC).
Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.

More on this story

Europe
EpiPen patent revoked in Europe
2 May 2018   The European Patent Office has revoked a patent covering Mylan’s EpiPen injector after finding that patent amendments contravened the European Patent Convention (EPC).
Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.

More features

Teva fights for re-listing of inhaler patents at US appeals court
CRISPR patents revoked following Nobel Prize winners’ withdrawal
White & Case hires experienced litigator from A&O Shearman
President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case